- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04814199
Use of Standardized Algorithm for the Management of Epidural Analgesia for Labor and Delivery
Use of Standardized Algorithm for the Management of Epidural Analgesia for Labor and Delivery: An Observational Cohort Study
Programmed Intermittent Epidural Bolus (PIEB) has become a standard technique for labour analgesia in many departments of anesthesia. Advantages to the former standard of care, continued epidural infusion (CEI), include reduced analgesic consumption , better maternal satisfaction and less occurrence of motor block . At Mount Sinai Hospital, the introduction of a bundle of changes in the management of labor analgesia including the use of PIEB, has resulted in an improvement of the quality of labor analgesia. This bundle of changes included labor catheter placement more often at L2/L3 interspace, more frequent use of fentanyl in the epidural loading dose, the implementation of a PIEB regimen and an increase in hourly baseline offer of local anesthetic.
A recent before-and-after study conducted by the investigators, comparing the current practice with the previous practice, which was based on CEI, identified that the incidence of women experiencing pain >3 (scale 0-10) (40% vs 30%) and the number of nurse-administered top-ups (24% vs 3%) were significantly reduced. However, despite that significant improvement, some 30% of women undergoing epidural analgesia still experience pain NRS >3 (NRS scale 0-10) during either first or second stage of labor.
Although the health care team attempts to manage epidurals as standardized as possible, there is some variation in practice resulting from the many stakeholders involved in the labor analgesia management, including anesthesiologists, obstetricians, nurses and patients. The investigators hypothesized that our most recent results may be explained by the lack of standardization of the management of epidural analgesia and that a standardized epidural catheter placement and a management algorithm may improve the efficacy of our epidural analgesia regimen.
The aim of this pilot study is to test the feasibility and efficacy of the use of a standardized algorithm for the management of labor epidural analgesia based on a PIEB regimen.
Study Overview
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G1X5
- Mount Sinai Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- request for epidural analgesia during labor
- ASA Physical Status II and III
Exclusion Criteria:
- patients requiring change in anesthetic management due to comorbidities or complications before initiation of epidural analgesia maintenance will be excluded.
- refusal to give written informed consent
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients using epidural management algorithm
Patients will be educated and given an algorithm to follow while in labour and after having an epidural catheter placed.
|
Patients will have a printed algorithm to follow while they are in labour with an epidural for pain management.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain score, questionnaire
Time Frame: 24 hours
|
Pain score using verbal numerical rating scale (VNRS) (0-10, where 0=no pain and 10=worst pain ever). This will be assessed hourly following epidural placement, as per institutional guidelines, until the patient delivers. The primary outcome of the study will be the presence of pain (NRS ≥ 3) at any time during the first and second stage of labor, after the establishment of an effective loading dose (pain NRS ≤ 1/10). |
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Upper sensory block level
Time Frame: 24 hours
|
The upper sensory block level to ice is defined as the dermatome at which there is an altered cold perception without complete sensitivity loss.
This will be assessed hourly following epidural placement, as per institutional guidelines, until the patient delivers.
|
24 hours
|
Motor block score using Bromage score
Time Frame: 24 hours
|
Motor block will be assessed with the Bromage score: 0 = able to raise the extended leg; 1 = unable to raise the extended leg but able to flex knees; 2 = unable to flex knees, but able to flex ankle; 3 = unable to flex ankle.
This will be assessed hourly following epidural placement, as per institutional guidelines, until the patient delivers.
|
24 hours
|
Blood pressure
Time Frame: 24 hours
|
Blood pressure measured hourly following epidural placement, as per institutional guidelines, until the patient delivers.
|
24 hours
|
Heart rate
Time Frame: 24 hours
|
Heart rate measured hourly following epidural placement, as per institutional guidelines, until the patient delivers.
|
24 hours
|
Number of patient controlled epidural analgesia button presses
Time Frame: 24 hours
|
Need for supplementary analgesia: the number of patient controlled epidural analgesia button presses will be recorded.
|
24 hours
|
Number of top ups administered by nurses or physicians
Time Frame: 24 hours
|
Need for supplementary analgesia: the number of top ups administered by nurses or physicians will be recorded.
|
24 hours
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21-02
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labor Pain
-
Cukurova UniversityRecruitingLabor Pain, Labor Perception, Hormone Levels and Childbirth ComfortTurkey
-
Soovu Labs Inc.Virginia Mason Hospital/Medical CenterNot yet recruiting
-
Bogomolets National Medical UniversityCompleted
-
Martin-Luther-Universität Halle-WittenbergRecruiting
-
Maimonides Medical CenterTerminated
-
Aretaieio HospitalRecruitingLabor Pain | Pain, Labor | EpiduralGreece
-
Mashhad University of Medical SciencesTerminatedDecrease Labor Pain
-
Amasya UniversityAtatürk UniversityNot yet recruitingSatisfaction, Patient | Pain, Labor
-
University Medical Centre LjubljanaCompletedLabor Pain | Labor; Prolonged, First Stage | Labor; Prolonged, Second StageSlovenia
Clinical Trials on Algorithm
-
University of ArizonaUnknown
-
University of California, San FranciscoEko Devices, Inc.CompletedAortic Valve Stenosis | Mitral Regurgitation | Heart Murmurs | Valvular Heart DiseaseUnited States
-
ResMedCompletedObstructive Sleep Apnea (OSA)Australia
-
Johann Wolfgang Goethe University HospitalHemoSonics LLCTerminatedHemorrhage | BleedingGermany
-
Ottawa Heart Institute Research CorporationActive, not recruitingMitral RegurgitationCanada
-
University of OxfordUnknownHeart Failure, SystolicUnited Kingdom
-
University of UtahRecruiting
-
Kıvanç AkçaHacettepe UniversityCompleted
-
Moorfields Eye Hospital NHS Foundation TrustCompletedGlaucoma | HealthyUnited Kingdom
-
Centre Hospitalier Universitaire, AmiensCentre Hospitalier Universitaire Dijon; Centre Hospitalier de Beauvais; Central... and other collaboratorsRecruitingSmall Bowel ObstructionFrance